Gamida Cell Reports Second Quarter and First Half 2023 Finan

Strong start for Omisirge® launch with significant payer coverage and number of transplant centers onboarded exceeding expectations


Company continues to pursue strategic partnership to further...
-Today at 07:02 am- MarketScreener

Related Keywords

Israel , Israeli , Usama Gergis , Terry Coelho , Steven Devine , Abbey Jenkins , Michele Korfin , Morgan Stanley , Transactions Committee , Drug Administration , Twitter , Sidney Kimmel Cancer Center , Israeli Innovation Authority , Community Fund , Moelis Company , Insightec Ltd , International Society For Cell , Nasdaq , National Marrow Donor Program , Gamida Cell Inc , Gamida Cell Ltd , Medicaid Services , Department Of Veterans Affairs , Department Of Defense , Veterans Affairs , Exchange Commission , Centers For Medicare , Thomas Jefferson University , Emissions Solutions Inc , Gamida Cell , Chief Executive Officer , Chief Operating , Chief Commercial Officer , Quarter Highlights , Gamida Cell Assist , Cellular Therapy , Chief Financial Officer , Chief Financial , Jeremy Blank , Chief Investment Officer , York Capital Management , Vice President , Advanced Emissions Solutions , Investor Day , Chief Medical Officer , International Society , Gene Therapy , Science Translational Medicine , Omisirge Phase , All Rights , Private Securities Litigation Reform Act , Risk Factors , Quarterly Report , Fair Value , Markets ,